title: Isolation of human islets from partially pancreatectomized patients.
abstract: Investigations into the pathogenesis of type 2 diabetes and islets of Langerhans malfunction (1) have been hampered by the limited availability of type 2 diabetic islets from organ donors(2). Here we share our protocol for isolating islets from human pancreatic tissue obtained from type 2 diabetic and non-diabetic patients who have undergone partial pancreatectomy due to different pancreatic diseases (benign or malignant pancreatic tumors, chronic pancreatitis, and common bile duct or duodenal tumors). All patients involved gave their consent to this study, which had also been approved by the local ethics committee. The surgical specimens were immediately delivered to the pathologist who selected soft and healthy appearing pancreatic tissue for islet isolation, retaining the damaged tissue for diagnostic purposes. We found that to isolate more than 1,000 islets, we had to begin with at least 2 g of pancreatic tissue. Also essential to our protocol was to visibly distend the tissue when injecting the enzyme-containing media and subsequently mince it to aid digestion by increasing the surface area. To extend the applicability of our protocol to include the occasional case in which a large amount (>15g) of human pancreatic tissue is available , we used a Ricordi chamber (50 ml) to digest the tissue. During digestion, we manually shook the Ricordi chamber(3) at an intensity that varied by specimen according to its level of tissue fibrosis. A discontinous Ficoll gradient was then used to separate the islets from acinar tissue. We noted that the tissue pellet should be small enough to be homogenously resuspended in Ficoll medium with a density of 1.125 g/ml. After isolation, we cultured the islets under stress free conditions (no shaking or rotation) with 5% CO(2;) at 37 °C for at least 48 h in order to facilitate their functional recovery. Widespread application of our protocol and its future improvement could enable the timely harvesting of large quantities of human islets from diabetic and clinically matched non-diabetic subjects, greatly advancing type 2 diabetes research.
authors.affiliation: Department of GI-, Thorax- and Vascular Surgery, University Hospital Carl Gustav Carus, University of Technology Dresden.
authors.forename: Gregor
authors.initials: G
authors.lastname: Bötticher
authors.forename: Doroth
authors.initials: D
authors.lastname: Sturm
authors.forename: Florian
authors.initials: F
authors.lastname: Ehehalt
authors.forename: Klaus P
authors.initials: KP
authors.lastname: Knoch
authors.forename: Stephan
authors.initials: S
authors.lastname: Kersting
authors.forename: Robert
authors.initials: R
authors.lastname: Grützmann
authors.forename: Gustavo B
authors.initials: GB
authors.lastname: Baretton
authors.forename: Michele
authors.initials: M
authors.lastname: Solimena
authors.forename: Hans D
authors.initials: HD
authors.lastname: Saeger
mesh_terms: D003584:Cytological Techniques / Q000379:methods*; D003924:Diabetes Mellitus, Type 2 / Q000473:pathology; D006801:Humans; D007515:Islets of Langerhans / Q000166:cytology*; D010179:Pancreas / Q000166:cytology* / Q000601:surgery; D010180:Pancreatectomy